Fatal acute hepatitis after sequential treatment with levofloxacin, doxycycline, and naproxen in a patient presenting with acute Mycoplasma pneumoniae infection

Clinical Therapeutics

Volumn 31, Issue 5, 2009, Pages 1014-1019

  Carrascosa, Miguel F ^a   Lucena, María Isabel ^b   Andrade, Raúl J ^b   Caviedes, José Ramón S ^a   Lavín, Antonio C ^a   Mones, Juan C ^a   Rivero, Andrea P ^a   Serrano, Vicente B ^c  

^a HOSPITAL DE LAREDO   (Spain)

^b HOSPITAL UNIVERSITARIO VIRGEN DE LA VICTORIA   (Spain)

^c HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

Author keywords

acute hepatitis; CIOMS RUCAM scale; doxycycline; drug induced liver injury (DILI); levo floxacin; Mycoplasma pneumoniae; naproxen; pneumonia

Indexed keywords

C REACTIVE PROTEIN; CISPLATIN; DOXYCYCLINE; LEVOFLOXACIN; NAPROXEN;

ACUTE HEPATITIS; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; AUTOPSY; BLOOD CULTURE; CASE REPORT; CHOLESTASIS; COMMUNITY ACQUIRED PNEUMONIA; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ERYTHROCYTE SEDIMENTATION RATE; FATALITY; HEPATIC ENCEPHALOPATHY; HEPATOMEGALY; HUMAN; HYPERBILIRUBINEMIA; HYPOPHARYNX CARCINOMA; JAUNDICE; LIVER BIOPSY; LIVER FAILURE; LIVER NECROSIS; MALE; MYCOPLASMA PNEUMONIA; MYCOPLASMA PNEUMONIAE; PERICARDITIS; SQUAMOUS CELL CARCINOMA;

ACUTE DISEASE; ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DOXYCYCLINE; FATAL OUTCOME; HEPATITIS; HEPATITIS, TOXIC; HUMANS; LIVER FAILURE, ACUTE; MALE; MIDDLE AGED; NAPROXEN; OFLOXACIN; PERICARDITIS; PNEUMONIA, MYCOPLASMA;

EID: 66949171014     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/j.clinthera.2009.05.012     Document Type: Article

References (20)

1. Ostapowicz G., Fontana R.J., Schiødt F.V., et al., the Acute Liver Failure Study Group. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med. 137 (2002) 947-954
2. Zimmerman H.J. Hepatotoxicity: The Adverse Effects of Drugs and Other Chemicals on the Liver. 2nd ed (1999), Lippincott Williams & Wilkins, Philadelphia, Pa
3. Danan G., and Benichou C. Causality assessment of adverse reactions to drugs-I. A novel method based on the conclusions of international consensus meetings: Application to drug-induced liver injuries. J Clin Epidemiol. 46 (1993) 1323-1330
4. Naranjo C.A., Busto U., Sellers E.M., et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 30 (1981) 239-245
5. Baum S.G. Mycoplasma pneumoniae and atypical pneumonia. In: Mandell G.L., Bennett J.E., and Dolin R. (Eds). Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. 6th ed (2005), Elsevier/Churchill Livingstone, New York, NY 2271-2280
6. Grüllich C., Baumert T.F., and Blum H.E. Acute Mycoplasma pneumoniae infection presenting as cholestatic hepatitis. J Clin Microbiol. 41 (2003) 514-515
7. Romero-Gómez M., Otero M.A., Sánchez-Muñoz D., et al. Acute hepatitis due to Mycoplasma pneumoniae infection without lung involvement in adult patients. J Hepatol. 44 (2006) 827-828
8. Suzuyama Y., Iwasaki H., Izumikawa K., and Hara K. Clinical complications of Mycoplasma pneumoniae disease-other organs. Yale J Biol Med. 56 (1983) 487-491
9. Adelson-Mitty J. Mycoplasma pneumoniae infection in adults. http://www.uptodateonline.com/online/content/topic.do?topicKey=pulm_inf/10170 Accessed January 6, 2009
10. Mas A., and Rodés J. Fulminant hepatic failure. Lancet. 349 (1997) 1081-1085
11. Lee W.M. Acute liver failure [published correction appears in N Engl J Med. 1994;330:584]. N Engl J Med. 329 (1993) 1862-1872
12. Spahr L., Rubbia-Brandt L., Marinescu O., et al. Acute fatal hepatitis related to levofloxacin. J Hepatol. 35 (2001) 308-309
13. Rostom A., Goldkind L., and Laine L. Nonsteroidal anti-inflammatory drugs and hepatic toxicity: A systematic review of randomized controlled trials in arthritis patients. Clin Gastroenterol Hepatol. 3 (2005) 489-498
14. Lucena M.I., Andrade R.J., Rodrigo L., et al. Trovafloxacin-induced acute hepatitis. Clin Infect Dis. 30 (2000) 400-401
15. Heaton P.C., Fenwick S.R., and Brewer D.E. Association between tetracycline or doxycycline and hepatotoxicity: A population based case-control study. J Clin Pharm Ther. 32 (2007) 483-487
16. Björnsson E., Lindberg J., and Olsson R. Liver reactions to oral low-dose tetracyclines. Scand J Gastroenterol. 32 (1997) 390-395
17. Andrade R.J., Lucena M.I., Fernández M.C., et al., the Spanish Group for the Study of Drug-Induced Liver Disease. Drug-induced liver injury: An analysis of 461 incidences submitted to the Spanish registry over a 10-year period [published correction appears in Gastroenterology. 2005;129:1808]. Gastroenterology. 129 (2005) 512-521
18. Chalasani N., Fontana R., Bonkovsky M.D., et al., the Drug Induced Liver Injury Network (DILIN). Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States. Gastroenterology. 135 (2008) 1924-1934
19. Chalasani N., Fontana R., Bonkovsky M.D., et al., the Drug Induced Liver Injury Network (DILIN). Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States. Gastroenterology. 135 (2008) 1934.e1-1934.e4
20. García-Cortés M., Lucena M.I., Pachkoria K., et al., the Spanish Group for the Study of Drug-induced Liver Disease (grupo de Estudio para las Hepatopatias Asociadas a Medica-mentos, Geham). Evaluation of Naranjo adverse drug reactions probability scale in causality assessment of drug-induced liver injury. Aliment Pharmacol Ther. 27 (2008) 780-789